ViraxClear™

If there’s one thing the world has learned so far during the COVID-19 pandemic, it’s the important role of testing for a disease. Knowing who has the virus and who doesn’t provides critical information for entire regions. ViraxClear distributes a range of highly accurate diagnostic testing kits and machines, achieving global market penetration through high quality and low prices.

Products

Influenza A/B+COVID-19/RSV Combo Ag Test (self-testing)

This test is an in vitro immunochromatographic assay for the qualitative and differential detection of nucleocapsid protein antigen from influenza A (including the subtype H1 N1), influenza B, respiratory syncytial virus and/or SARS-CoV-2 in nasal swab specimens. It is intended to aid in the rapid diagnosis of influenza A, influenza B, respiratory syncytial virus and/or SARS-CoV-2 infections. This test provides only a preliminary test result. Therefore, any reactive specimen with the Influenza A/B+COVID-19/RSV Combo Ag Test must be confirmed with alternative testing method(s) and clinical findings.

— Non-invasive sampling
— Fast – result available in 15 minutes
— Read test results visually
— Do not require test equipment

Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kit

This kit is intended for qualitative detection and differentiation of nucleic acids from Monkeypox and Varicella-Zoster viruses. The test is advised for use as an aid in the rapid diagnosis of the viruses in human serum and lesion exudate specimens. It provides a preliminary results only. The final confirmation should be based on clinical diagnostic results.

— High sensitivity – 200 copies/ml
— Efficient – 96 samples/30 mins
— Endogenous internal control
— dUTP/UDG anti-contamination system

Monkeypox Virus Antigen Rapid Test Kit

This test is used for in vitro qualitative detection of the monkeypox virus antigen in the oropharyngeal (throat) swabs and skin exudates of humans by colloidal gold immunochromatography. For professional use only.

— Fast – 15 minutes for results to be read by naked eye
— Convenient – sample tube with prefilled extraction buffer
— Early – identifies acute or early infection

COVID-19 Rapid Antibody IgC/IgM Test

These tests track down antibodies. The ability to detect antibodies against SARS-CoV-2 can reveal whether a patient has had COVID-19, even if they were never diagnosed or felt sick.

— Rapid results – within 15 minutes
— Accurate – 98% accuracy
— Flexible – can be done at home
— Easy to use – simple finger prick

COVID-19 Antigen Test Kit

These antigen tests are immunoassays that use highly sensitive monoclonal antibodies to detect the presence of Coronaviruses.

— Highly portable and easy to operate
— Prepacked eluent buffer, ready to use
— Good consistency with PCR test
— Time-saving – 10 minutes
— Room-temperature storage (4–30°C)

COVID-19 Fluorescence PCR Detection Kit

Simple workflow with no requirement for a lab or centrifuge for easy deployment in rural areas, places of work or large office buildings etc.

— Simple operation – real-time PCR without RNA extraction
— Fast – sample to result in less than half an hour
— Pollution-free – one-step RT-PCR
— Extremely cost-effective as compared to competitors
— CE Certified

COVID-19 Neutralizing Antibody Test

Detects how many antibodies a given patient has after vaccination to assess the effect of the vaccine. This test is not only limited to research studies in labs but is also appropriate for hospital use.

— Rapid immunity evaluation within 25 minutes
— Proved by clinical evaluation
— Compatible with serum, plasma, whole and fingertip blood
— Compatible with optical reading device for point of care

Human Papillomavirus Real Time PCR Kit

This kit is a qualitative PCR assay intended to detect 18 high-risk genotypes of the human papillomavirus (HPV), including HPV-16, HPV-18 and other 16 common oncogenic types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, 53, 82 and 26). Specific genotypes identified can assist doctors to further deciding triage and treatment and to reduce morbidity and prevalence of cervical cancer.

— Easy screening – 100 mins to complete 96 tests
— Reliable performance – high sensitivity and specificity validated in clinical sites
— Cytologic sample detectable (Thin Prep® and BD SurePath™)
— Cost-saving – compatible for most mainstream real-time PCR instruments, no specific system required
— Fulfillment of clinical use – respectively report HPV-16 and HPV-18 as primary evidence for cervical cancer screening

Avian Influenza A Virus (AIV) – H5/H7/H9 Real-Time PCR Detection Kit

This PCR kit is intended for the detection and differentiation of ribonucleic acids (RNA) from AIV and its H5, H7 and H9 subtypes, including the virulent H5N1 strain. The test is advised for use in laboratory settings and to help healthcare professionals accurately identify an AIV infection. It may also serve as a valuable initial screening test for individuals that have been exposed to AIV infected livestock or a high-risk environment.

— Human nasopharyngeal and oropharyngeal swab samples
— Runs on a wide range of commonly available extraction and RT-PCR instruments
— Analytical sensitivity of 5 RNA copies/reaction
— High specificity – no cross reactivity seen to a range of other common respiratory pathogens